Theratechnologies files Form 6-K on special meeting

Theratechnologies Inc. furnished a Form 6-K as a foreign private issuer for August 2025.

Rhea-AI Filing Summary

Theratechnologies Inc. furnished a Form 6-K as a foreign private issuer for August 2025. The filing mainly forwards materials for a special meeting of shareholders, including a notice of meeting and a management proxy circular, both dated August 12, 2025.

The report also includes a form of proxy, a voting instruction form, and a letter of transmittal as exhibits, indicating shareholders are being asked to vote on matters described in the proxy materials. The document is signed on behalf of Theratechnologies by its General Counsel and Corporate Secretary, Jocelyn Lafond, dated August 18, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Theratechnologies Inc. (THTX) report in its August 2025 Form 6-K?

Theratechnologies Inc. reports the furnishing of materials for a special shareholders’ meeting. These include a notice, management proxy circular, proxy form, voting instruction form, and letter of transmittal, all tied to shareholder voting matters.

What exhibits are included in Theratechnologies (THTX) August 2025 Form 6-K?

The filing lists five exhibits: a Notice of Special Meeting of Shareholders, a Management Proxy Circular, a Form of Proxy, a Voting Instruction Form, and a Letter of Transmittal, each supporting the upcoming shareholder meeting and related voting process.

What is the purpose of the special meeting materials for Theratechnologies (THTX)?

The materials support a special meeting of shareholders by outlining proposed matters and providing tools for voting. They include a management proxy circular and forms enabling shareholders and intermediaries to submit their votes on the specified agenda items.

Who signed Theratechnologies Inc. (THTX) August 2025 Form 6-K?

The Form 6-K was signed on behalf of Theratechnologies Inc. by Jocelyn Lafond. Lafond is identified as the company’s General Counsel and Corporate Secretary, indicating a senior legal and governance officer authorized the submission.

When are Theratechnologies (THTX) special meeting proxy materials dated?

The notice of special meeting of shareholders and the management proxy circular are both dated August 12, 2025. The Form 6-K that furnishes these documents is dated August 18, 2025, reflecting subsequent submission of the compiled materials.

Is Theratechnologies Inc. (THTX) a foreign private issuer under U.S. securities rules?

Yes. Theratechnologies Inc. filed a Form 6-K as a foreign private issuer under the Securities Exchange Act of 1934. This form is used by non-U.S. companies to furnish information, including shareholder meeting materials, to U.S. investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2025 - 08:15 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025.

Commission File Number 001-35203

Theratechnologies Inc.

(Translation of registrant’s name into English)

2015 Peel Street, Suite 1100

Montreal, Quebec

H3A 1T8, Canada

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☒ Form 20-F   ☐ Form 40-F

EXHIBIT INDEX

Exhibit No.		Description of Exhibit
99.1		Notice of Special Meeting of Shareholders dated August 12, 2025
99.2		Management Proxy Circular dated August 12, 2025
99.3		Form of Proxy
99.4		Voting Instruction Form
99.5		Letter of Transmittal

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

THERATECHNOLOGIES INC.
By:		/s/ Jocelyn Lafond
Name:		Jocelyn Lafond
Title:		General Counsel and Corporate Secretary

Date: August 18, 2025